Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 1906 AL 1920

A functional role for alpha-synuclein in neuroimmune responses

Heiden DL, Monogue B, Ali MDH, Beckham JD.

J Neuroimmunol. 2023 Mar 15;376:578047. doi: 10.1016/j.jneuroim.2023.578047. Epub 2023 Feb 8.

A Case of Parinaud Syndrome in a Patient with Parkinson's Disease: Causal Association or Co-incidental?

Dubey S, Ghosh R, Ray BK, Gutiérrez-Ortiz C, Benito-León J.

Neurol India. 2023 Jan-Feb;71(1):129-131. doi: 10.4103/0028-3886.370439.

The Role of LRRK2 in Intracellular Organelle Dynamics

Boecker CA.

J Mol Biol. 2023 Jun 15;435(12):167998. doi: 10.1016/j.jmb.2023.167998. Epub 2023 Feb 9.

Insights into the cellular consequences of LRRK2-mediated Rab protein phosphorylation

Fasiczka R, Naaldijk Y, Brahmia B, Hilfiker S.

Biochem Soc Trans. 2023 Apr 26;51(2):587-595. doi: 10.1042/BST20201145.

Neuroprotection of Thioredoxin1 in the Brain

Noriega-Navarro R, Martínez-Tapia RJ, Osornio-Hernández JL, Landa-Navarro L, Xinastle-Castillo LO, Landa A, Navarro L.

Curr Alzheimer Res. 2023;20(5):318-340. doi: 10.2174/1567205020666230809145041.

Totally tubular: ASO-mediated knock-down of G2019S -Lrrk2 modulates lysosomal tubule-associated antigen presentation in macrophages

Wallings RL, Mark JR, Staley HA, Gillett DA, Neighbarger N, Kordasiewicz H, Hirst WD, Tansey MG.

bioRxiv [Preprint]. 2023 Jul 15:2023.07.14.549028. doi: 10.1101/2023.07.14.549028.

The Parkinson's drug entacapone disrupts gut microbiome homeostasis via iron sequestration

Pereira FC, Ge X, Kristensen JM, Kirkegaard RH, Maritsch K, Zhu Y, Decorte M, Hausmann B, Berry D, Wasmund K, Schintlmeister A, Boettcher T, Cheng JX, Wagner M.

bioRxiv [Preprint]. 2023 Nov 13:2023.11.12.566429. doi: 10.1101/2023.11.12.566429.

Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotype

Kearney PJ, Zhang Y, Tan Y, Kahuno E, Conklin TL, Fagan RR, Pavchinskiy RG, Shafer SA, Yue Z, Melikian HE.

Res Sq [Preprint]. 2023 May 25:rs.3.rs-2944614. doi: 10.21203/rs.3.rs-2944614/v1.

Liquid-liquid phase separation of α-synuclein is highly sensitive to sequence complexity

Mahapatra A, Newberry RW.

bioRxiv [Preprint]. 2023 Nov 7:2023.08.03.551831. doi: 10.1101/2023.08.03.551831.

Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson's Disease

Tryphena KP, Anuradha U, Kumar R, Rajan S, Srivastava S, Singh SB, Khatri DK.

J Alzheimers Dis. 2023;94(s1):S187-S202. doi: 10.3233/JAD-220449.

Restorative cell and gene therapies for Parkinson's disease

Barker RA, Björklund A.

Handb Clin Neurol. 2023;193:211-226. doi: 10.1016/B978-0-323-85555-6.00012-6.

Cell therapy for Parkinson's disease with induced pluripotent stem cells

Morizane A.

Inflamm Regen. 2023 Feb 27;43(1):16. doi: 10.1186/s41232-023-00269-3.

The emerging role of circular RNAs in Parkinson's disease

Liao J, Zhang Q, Huang J, He H, Lei J, Shen Y, Wang J, Xiao Y.

Front Neurosci. 2023 Feb 16;17:1137363. doi: 10.3389/fnins.2023.1137363. eCollection 2023.

A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson's disease: beneficial or detrimental effects

Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Saad HM, Batiha GE.

Inflammopharmacology. 2023 Apr;31(2):673-688. doi: 10.1007/s10787-023-01192-2. Epub 2023 Mar 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias